Europe Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bo

Europe Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)

The Europe bovine diagnostics market is expected to grow from US$ 301.31 million in 2022 to US$ 511.86 million by 2030. It is estimated to grow at a CAGR of 6.8% from 2022 to 2030.

Increasing Number of Product Launches Fuels Europe Bovine Diagnostics Market

Continuous research and development efforts allow veterinary diagnostics companies to launch various innovative diagnostics products that provide rapid results. In addition, growing awareness among end users through the government’s educative and knowledge-sharing programs has encouraged these companies to introduce advanced diagnostics products. A few of the recent product launches in the Europe bovine diagnostics market have been mentioned below.

In June 2023, Zoetis, Inc launched Vetscan Mastigram+, an on-farm mastitis diagnostic solution that provides results 8 hours before the next milking. The Vetscan Mastigram+ uses a flow dipstick test to detect Gram-positive mastitis in cattle. The product would detect the presence of Gram-positive pathogens in cow milk with 99% sensitivity and 100% specificity, along with differentiating between for Gram-positive and Gram-negative bacteria.
In June 2023, Neogen Corporation launched Igenity BeefXDairy, a DNA test for beef-on-dairy cattle. The test would provide insights into the traits such as carcass quality, average daily gain, and the Igenity Terminal Index to the producers. In addition, it would allow buyers to receive breed composition data to help them with optimal cattle health management and maximize the cattle product yield.
In August 2023, Biotangents, a Scottish biotech company, announced the launch of its next-generation molecular diagnostic assay—AmpliSpec LAB Mastitis. The company claims that AmpliSpec LAB Mastitis is a highly sophisticated assay with 93% sensitivity and 95% specificity in detecting mastitis pathogens in dairy cows.

Europe Bovine Diagnostics Market Overview

The Europe bovine diagnostics market in Europe is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The market growth in the region is attributed to the launches and availability of veterinary diagnostics products, and the increasing number of government initiatives and investments in preventive measures to minimize infections in cattle. The UK contributes significantly to the Europe bovine diagnostics market in Europe. The country has all the resources available to diagnose diseases in livestock and other animals. Public and private entities largely contribute to the Europe bovine diagnostics market in the country. For example, Axiom Veterinary Laboratories is one of the largest providers of veterinary diagnostic testing for livestock in the UK. It offers a complete range of diagnostic testing and the CHeCS programs with assured quality tests at cost-effective prices. Further, the country has the highest incidence of bTB. According to data from the UK government, over 27,000 cattle were slaughtered to curb the spread of bTB in 2020. Innovative products offered by companies in the Europe bovine diagnostics market assist other livestock therapeutics companies prevent and provide effective treatment based on the diagnosis. In March 2020, scientists at Randox Food Diagnostics introduced a bovine pathogen array against the world’s most prevalent bovine viruses, bacteria, and parasites.

Europe Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Bovine Diagnostics Market Segmentation

The Europe bovine diagnostics market is segmented into product, disease type, end user, and country.

Based on product, the Europe bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the Europe bovine diagnostics market in 2022.

Based on disease type, the Europe bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the Europe bovine diagnostics market in 2022.

Based on end user, the Europe bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the Europe bovine diagnostics market in 2022.

Based on country, the Europe bovine diagnostics market is segmented int o the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe bovine diagnostics market in 2022.

bioMerieux SA, Enfer Labs, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, PBD Biotech Ltd, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe bovine diagnostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Bovine Diagnostics Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe Bovine Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.